What is Generic Drugs?
Historical Background
Key Points
8 points- 1.
Contain the same active ingredient, dosage form, strength, route of administration, and intended use as the brand-name drug.
- 2.
Must meet the same quality standards as brand-name drugs.
- 3.
Typically much cheaper than brand-name drugs (often 20-80% cheaper).
- 4.
Increase access to medicines, particularly in developing countries.
- 5.
Promote competition in the pharmaceutical market.
- 6.
Subject to regulatory approval by agencies like the Central Drugs Standard Control Organization (CDSCO) in India.
- 7.
Generic drug manufacturers must demonstrate bioequivalence to the brand-name drug.
- 8.
Play a crucial role in reducing healthcare costs.
Visual Insights
Generic Drug Approval Process in India
Flowchart illustrating the steps involved in the approval process for generic drugs in India, highlighting the role of the CDSCO.
- 1.Application Submission to CDSCO
- 2.Review of Bioequivalence Data
- 3.Quality Assessment & GMP Inspection
- 4.CDSCO Approval
- 5.Manufacturing & Marketing
- 6.Post-Market Surveillance
Recent Developments
5 developmentsGovernment policies to promote the use of generic drugs.
Increased focus on ensuring the quality and safety of generic drugs.
Challenges related to public perception and trust in generic drugs.
Growing market for biosimilars (generic versions of biologic drugs).
Efforts to reduce the price differential between brand-name and generic drugs.